Agappe Diagnostics

1. Executive Summary (Confidence: high)

Agappe Diagnostics (ADL) is one of the fastest-growing IVD companies globally, marking over 30 years of excellence in 2025. From its state-of-the-art 200,000 square-foot manufacturing facility in Kerala, India, the company has successfully expanded its footprint to over 90 countries. With revenues in the range of INR 500-750 crore and a strong distribution network of over 1,000 partners, Agappe has established itself as the second-largest manufacturer of clinical chemistry reagents in India. By adhering to the principles of Quality, Innovation, and Affordability, the company has moved from an imports-only model to a fully integrated, technology-driven pioneer in clinical chemistry, hematology, and molecular diagnostics.